Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
*Correspondence: Jos C
A study published in the Journal of Endocrinology and Metabolism found that AOD 9604 had no negative impact on blood glucose levels
Factors like age, exposure to environmental pollutants, and even overindulging in pretty much anything (refined sugars, processed foods, alcohol, etc.) can deplete glutathione levels, so supporting glutathione production in the body is essential to keep your cells at peak wellness
Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women
